Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF antagonist

Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF antagonist

US Patent 11130805 · Granted Sep 28, 2021

Estimated economic value: $11,242,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EphA3 directed CAR-T cells for treatment of tumors2024
EphA3 directed CAR-T cells for treatment of tumors2024
A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method 2023
Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab2023
Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab2023
Method of reducing tumor relapse rate in immunotherapy by administration of lenz2021
Method of reducing tumor relapse rate in immunotherapy by administration of lenz2021
Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy2021
Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy2021
Methods of treating immunotherapy-related toxicity using a GM-CSF antagonist2020
Methods of treating immunotherapy-related toxicity using a GM-CSF antagonist2020
A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method 2020